March 6th 2025
The authors examine the risks of extractables and leachables and present solutions that emphasize the importance of a strategic multi-prong approach.
NGS abbreviates drug discovery timelines.
Addressing the Analytical Challenge of Meeting Quick Turnaround Times (AAPS PharmSci 360)
November 2nd 2023Hollie Barton, senior director, Chromatographic Services, for the PPD clinical research business of Thermo Fisher Scientific, discusses ways that labs are addressing the pressure of rapid analytical turnaround times.